Jan Dürig

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Mattia D’Agostino, David A. Cairns, Juan José Lahuerta et al. · Journal of Clinical Oncology · 2022 · 407 citations · Full text

Medicine, Oncology, Molecular Oncology +15

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Tumor-derived exosomes modulate PD-L1 expression in monocytes

Franziska Haderk, Ralph Schulz, Murat Iskar et al. · Science Immunology · 2017 · 292 citations

Life Sciences, Immunology, Oncology +17

Cellular origin and pathophysiology of chronic lymphocytic leukemia

Marc Seifert, Ludger Sellmann, Johannes Bloehdorn et al. · The Journal of Experimental Medicine · 2012 · 279 citations · Full text

Life Sciences, Cell Biology, Hematology +14

miR-34a as part of the resistance network in chronic lymphocytic leukemia

Thorsten Zenz, Julia Mohr, Eric Eldering et al. · Blood · 2008 · 277 citations · Full text

Medicine, Molecular Biology, Oncology +14